Elisabet Lund Appointed CFO of VirtaMed

The new appointment, effective November 15, supports the company’s continued growth and expansion in the global digital surgery market

VirtaMed, the Zurich-based world leader in surgical simulation, has announced that Elisabet Lund has been appointed as Chief Financial Officer of the company, effective November 15, 2021.

Elisabet Lund – a former CFO for the Swedish vascular simulation company Mentice AB – brings over two decades of experience in senior finance and leadership to VirtaMed’s executive team.

“We are extremely pleased to welcome Elisabet to VirtaMed and benefit from her familiarity with the rapidly growing medical education industry,” said Dr. Raimundo Sierra, founder and CEO of VirtaMed. “Elisabet is the perfect fit to build on our strong financial position and support our team as it continues to develop.”

Elisabet Lund holds a Bachelor’s degree in Business Administration from the University of Gothenburg. Among her many accomplishments with Mentice AB includes listing the company on the Nasdaq First North Premier Growth Market in 2019.

“I am very excited about joining VirtaMed and look forward to the opportunity to work with a highly committed and professional team and to be a part of VirtaMed’s journey ahead,” said Lund.

Other Executives In the News

SourceVirtaMed
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy